| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977750 | Brachytherapy | 2012 | 6 Pages |
Abstract
The VAS scale reflected the change in the patients' QOL more precisely than the IPSS, which examines the frequency of lower urinary tract symptoms. Nocturia plays a key role in determining QOL. VAS could be a promising tool for assessing satisfaction in patients with lower urinary tract symptoms after PBT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Koji Okihara, Osamu Ukimura, Soh Ushijima, Kazumi Kamoi, Tsuyoshi Iwata, Kana Kobayashi, Yasuyuki Naitoh, Hideya Yamazaki, Akihiro Kawauchi, Tsuneharu Miki,